Durability of Immunity Is Low Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1, BA.2, and BA.3 Variants After Second and Third Vaccinations in Children and Young Adults With Inflammatory Bowel Disease Receiving Biologics

Gastroenterology. 2022 Dec;163(6):1672-1675. doi: 10.1053/j.gastro.2022.08.009. Epub 2022 Aug 10.

¹ Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
² Department of Pediatrics, Connecticut Children's Medical Center, Hartford, Connecticut; School of Medicine, University of Connecticut, Farmington, Connecticut.
³ Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland. Electronic address: Surender.Khurana@fda.hhs.gov.

No abstract available

Publication types